Instil Bio TIL
NASDAQ TIL
$7.58 +0.15 (+2.02%)
As of: Aug 21, 2026 · 3:52 PM EDT

Instil Bio (TIL) Profit After Tax (2020 - 2026)

Instil Bio (TIL) posted quarterly Profit After Tax of -$4.2 million for Q1 2026, up 85.39% year-over-year from -$2.2 million in Q1 2025, and up 49.3% quarter-over-quarter from -$8.2 million in Q4 2025.

Instil Bio (TIL) Profit After Tax (2020 - 2026) Analysis & Trends

Instil Bio's Profit After Tax history runs 7 years deep, the most recent figure standing at -$4.2 million for Q1 2026.

  • In Q1 2026, Profit After Tax rose 85.39% year-over-year to -$4.2 million; the TTM figure through Mar 2026 stood at -$47.1 million (up 39.56% YoY), while the FY2025 annual figure was -$71.4 million, up 3.73% from the prior year.
  • Profit After Tax for Q1 2026 stood at -$4.2 million, up from -$8.2 million in the prior quarter.
  • The five-year high for Profit After Tax was -$4.2 million in Q1 2026, with the low at -$67.2 million in Q3 2023.
  • The 5-year median for Profit After Tax is -$22.9 million (2024), against an average of -$31.1 million.
  • The sharpest annual moves came in 2022 and 2026: Profit After Tax tumbled 133.99% in 2022, then jumped 85.39% in 2026.
  • Instil Bio's Profit After Tax stood at -$54.2 million in 2022, then surged by 76.44% to -$12.8 million in 2023, then climbed by 8.27% to -$11.7 million in 2024, then jumped by 30.13% to -$8.2 million in 2025, then jumped by 49.3% to -$4.2 million in 2026.
  • Business Quant data shows TIL's Profit After Tax at -$4.2 million in Q1 2026, -$8.2 million in Q4 2025, and -$13.4 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) PAT (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn 1.10 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 1.30 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn 472.00 Mn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn -782.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 237.01 Mn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn 164.49 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn -355.03 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn -16.62 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn - 81.49 Mn
10 Instil Bio 51.68 Mn 51.68 Mn - -4.35 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 -4.35 Mn
Mar 31, 2026 -4.15 Mn
Dec 31, 2025 -8.19 Mn
Sep 30, 2025 -13.39 Mn
Jun 30, 2025 -21.39 Mn
Mar 31, 2025 -28.42 Mn
Dec 31, 2024 -11.72 Mn
Sep 30, 2024 -22.91 Mn
Jun 30, 2024 -14.92 Mn
Mar 31, 2024 -24.30 Mn
Dec 31, 2023 -12.78 Mn
Sep 30, 2023 -67.16 Mn
Jun 30, 2023 -18.66 Mn
Mar 31, 2023 -57.07 Mn
Dec 31, 2022 -54.25 Mn
Sep 30, 2022 -56.22 Mn
Jun 30, 2022 -58.99 Mn
Mar 31, 2022 -54.12 Mn
Dec 31, 2021 -55.33 Mn
Sep 30, 2021 -43.01 Mn